Clinical Risk Factors for Primary Graft Dysfunction after Lung Transplantation
Open accessThe DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
Rationale: Primary graft dysfunction (PGD) is the main cause of early morbidity and mortality after lung transplantation. Previous studies have yielded conflicting results for PGD risk factors. Objectives: We sought to identify donor, recipient, and perioperative risk factors for PGD. Methods: We performed a 10-center prospective cohort study enrolled between March 2002 and December 2010 (the Lung Transplant Outcomes Group). The primary outcome was International Society for Heart and Lung Transplantation grade 3 PGD at 48 or 72 hours post-transplant. The association of potential risk factors with PGD was analyzed using multivariable conditional logistic regression. Measurements and Main Results: A total of 1,255 patients from 10 centers were enrolled; 211 subjects (16.8%) developed grade 3 PGD. In multivariable models, independent risk factors for PGD were any history of donor smoking (odds ratio [OR], 1.8; 95% confidence interval [CI], 1.2–2.6; P = 0.002); FiO2 during allograft reperfusion (OR, 1.1 per 10% increase in FiO2; 95% CI, 1.0–1.2; P = 0.01); single lung transplant (OR, 2; 95% CI, 1.2–3.3; P = 0.008); use of cardiopulmonary bypass (OR, 3.4; 95% CI, 2.2–5.3; P < 0.001); overweight (OR, 1.8; 95% CI, 1.2–2.7; P = 0.01) and obese (OR, 2.3; 95% CI, 1.3–3.9; P = 0.004) recipient body mass index; preoperative sarcoidosis (OR, 2.5; 95% CI, 1.1–5.6; P = 0.03) or pulmonary arterial hypertension (OR, 3.5; 95% CI, 1.6–7.7; P = 0.002); and mean pulmonary artery pressure (OR, 1.3 per 10 mm Hg increase; 95% CI, 1.1–1.5; P < 0.001). PGD was significantly associated with 90-day (relative risk, 4.8; absolute risk increase, 18%; P < 0.001) and 1-year (relative risk, 3; absolute risk increase, 23%; P < 0.001) mortality. Conclusions: We identified grade 3 PGD risk factors, several of which are potentially modifiable and should be prioritized for future research aimed at preventative strategies. Clinical trial registered with www.clinicaltrials.gov (NCT00552357).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“We know from prior work that recipient characteristics including primary PH or pulmonary fibrosis and increasing mPAP are risk factors for PGD.29–31”
Citations
Cites
(2000) · New England Journal of Medicine · doi:10.1056/nejm200005043421801 · Cited by 12,941
Christie, J. D., Carby, M., Bag, R., Corris, P., Hertz, M., & Weill, D. (2005) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2004.11.049 · Cited by 762 · cited 1×
“In 2005, the International Society for Heart and Lung Transplantation (ISHLT) standardized the PGDdefinition to facilitate research on risk factors associated with the development of this syndrome (7).”
BackgroundSelf-citationChristie, J. D., Edwards, L. B., Kucheryavaya, A. Y., Benden, C., Dipchand, A. I., Dobbels, F., Kirk, R., Rahmel, A. O., Stehlik, J., & Hertz, M. I. (2012) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2012.08.004 · Cited by 630 · cited 2×
“Additionally, the most recent ISHLT report includes 2004–2010 as a single era when presenting survival analyses (34).”
BackgroundSelf-citationTransfusion-related Acute Lung Injury in the Critically Ill: Prospective Nested Case-Control Study
Gajic, O., Rana, R., Winters, J. L., Yilmaz, M., Mendez, J. L., Rickman, O. B., O'Byrne, M. M., Evenson, L. K., Malinchoc, M., DeGoey, S. R., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200702-271oc · Cited by 430 · cited 1×
“Nonetheless, because blood product transfusion in-and-of-itself is associated with ALI in at-risk groups this finding may warrant further research into mechanisms of increased grade 3 PGD risk (31).”
Impact of Immediate Primary Lung Allograft Dysfunction on Bronchiolitis Obliterans Syndrome
Daud, S. A., Yusen, R. D., Meyers, B. F., Chakinala, M. M., Walter, M. J., Aloush, A. A., Patterson, G. A., Trulock, E. P., & Hachem, R. R. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200608-1079oc · Cited by 420 · cited 5×
“Pulmonary arterial hypertension 12 (6) 28 (3)”
BackgroundMethodInfluentialPutensen, C., Theuerkauf, N., Zinserling, J., Wrigge, H., & Pelosi, P. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-8-200910200-00011 · Cited by 372
The Effect of Primary Graft Dysfunction on Survival after Lung Transplantation
Christie, J. D., Kotloff, R. M., Ahya, V. N., Tino, G., Pochettino, A., Gaughan, C., DeMissie, E., & Kimmel, S. E. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200409-1243oc · Cited by 351 · cited 1×
“The incidence of PGD is 10–30% and is the major cause of mortality within the first post-transplant year (1, 2).”
BackgroundSelf-citationEISNER, M. D., THOMPSON, T., HUDSON, L. D., LUCE, J. M., HAYDEN, D., SCHOENFELD, D., MATTHAY, M. A., & the Acute Respiratory Distress Syndrome Network (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.2.2011093 · Cited by 290
Clinical Risk Factors for Primary Graft Failure Following Lung Transplantation
Christie, J. D., Kotloff, R. M., Pochettino, A., Arcasoy, S. M., Rosengard, B. R., Landis, J. R., & Kimmel, S. E. (2003) · Chest · doi:10.1378/chest.124.4.1232 · Cited by 275 · cited 1×
“None of the previously identified donor variables, including sex, race, age, or mode of death were significantly associated with grade 3 PGD (14, 18, 20).”
BackgroundSelf-citationPrimary Graft Dysfunction and Long-term Pulmonary Function After Lung Transplantation
Whitson, B. A., Prekker, M. E., Herrington, C. S., Whelan, T. P. M., Radosevich, D. M., Hertz, M. I., & Dahlberg, P. S. (2007) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2007.07.018 · Cited by 265 · cited 1×
“PGD leads to increased duration of mechanical ventilation and intensive care unit length of stay, poor functional outcomes, and increased risk of bronchiolitis obliterans syndrome (3, 4).”
Background
Cited by
Items 501–600 of 698
Preventing the NET Negative in Primary Graft Dysfunction
Emtiazjoo, A. M., & Shilling, R. A. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201412-2218ed · Cited by 3
Choosing the right lungs for the right patient
Dark, J. H. (2013) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2013.08.018 · Cited by 3
O’Keefe, K., Kılıç, A., Pope‐Harman, A., Hayes, D., Kirkby, S. E., Higgins, R. S. D., & Whitson, B. A. (2014) · Experimental and Clinical Transplantation · doi:10.6002/ect.2013.0267 · Cited by 3
Bozso, S. J., & Nagendran, J. (2017) · American Journal of Transplantation · doi:10.1111/ajt.14413 · Cited by 3
“The authors report an incidence of PGD grade 3 at 72 hours of only 7%, which compares with contemporary reported rates of 17% (3).”
ResultDon’t Inhale: Acute Respiratory Distress Syndrome Risk and Tobacco Exposure in Patients with Sepsis
Diamond, J. M. (2022) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202201-0034ed · Cited by 3
Self-citationLung Allograft Dysfunction: Does Aspiration Hold the Key?
Pragman, A. A. (2022) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202210-1873ed · Cited by 3
Sella, N., Pettenuzzo, T., Congedi, S., Bisi, M., Gianino, G., Carolis, A. D., Bertoncello, C. A., Roccaforte, M., Zarantonello, F., Persona, P., et al. (2024) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2024.11.018 · Cited by 2
Miceli, V., Ferrigno, P., Centi, C., Carcione, C., Iannolo, G., Agnese, V., Iacono, G. L., Liotta, R., Conaldi, P. G., Pinzani, M., et al. (2025) · Heliyon · doi:10.1016/j.heliyon.2025.e42515 · Cited by 3
“While certain clinical factors in donors and recipients correlate with PGD, the reasons underlying variable lung damage in distinct patients are unclear [12].”
Prognostic impact of low muscle mass on clinical outcomes in patients who undergo lung transplant
Park, H. J., Choi, S. M., Na, K. J., Park, S., Lee, H. J., Kim, Y. T., Lim, W. H., Yoon, S. H., Lee, J. H., & Park, J. (2025) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2025.03.030 · Cited by 3
Self-citationPost–Ex Vivo Lung Perfusion Hypothermic Storage Limits Inflammation and Endothelial Dysfunction
Selim, J., Wolf, J. D., Soulié, M., Sage, É., Glorion, M., Fessler, J., Mulder, P. G. H., Vasse, M., Bellien, J., Djerada, Z., et al. (2025) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2025.07.007 · Cited by 3
Zhāng, P., Qiao, Z., Zhao, S., & Wu, K. (2025) · Transplant Immunology · doi:10.1016/j.trim.2025.102326 · Cited by 5
Early Postoperative Management of Lung Transplant Recipients
Trinh, B. N., Brzeziński, M., & Kukreja, J. (2022) · Thoracic surgery clinics/Thorac. surg. clin. · doi:10.1016/j.thorsurg.2021.11.006 · Cited by 3
Exploring predisposing factors and pathogenesis contributing to injuries of donor lungs
Yu, J., Zhang, N., Zhang, Z., Li, Y., Gao, J., Chen, C., & Wen, Z. (2022) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2022.2157264 · Cited by 2
“LTx has been identified as an independent risk factor for PGD [122].”
BackgroundPulmonary Hypertension in Orphan Lung Diseases
Montani, D., Thoré, P., Jutant, E., & Humbert, M. J. C. (2023) · Springer eBooks · doi:10.1007/978-3-031-12950-6_41 · Cited by 2
Ballesteros, B. L.-M., López‐de‐Andrés, A., Jiménez‐García, R., Zamorano‐León, J. J., Carabantes-Alarcón, D., Cuadrado‐Corrales, N., del-Barrio, J. L., Pérez‐Farinós, N., & de Miguel‐Díez, J. (2023) · Healthcare · doi:10.3390/healthcare11111534 · Cited by 2
“Thus, there are authors who have associated its use with a higher rate of complications [38], while others have reported a lower rejection rate in those patients treated with extracorporeal membrane oxygenation during surgery [39].”
BackgroundYu, J., Zhang, N., Zhang, Z., Fu, Y., Gao, J., Chen, G., & Wen, Z. (2023) · Asian Journal of Surgery · doi:10.1016/j.asjsur.2023.09.016 · Cited by 2
Ikeda, M., Aoyama, A., Fukuyama, J., Okuda, M., Yamazaki, K., Minatoya, K., Chen-Yoshikawa, T. F., Kayawake, H., Tanaka, S., Yamada, Y., et al. (2024) · JHLT Open · doi:10.1016/j.jhlto.2024.100070 · Cited by 2
“There were 2 cases of PAH in the ECMO group, and neither of them had PGD.”
InfluentialCuesta, V. M. M., Meñaca, A. M., Fernandez, D. I., Tello-Mena, S., Izquierdo‐Cuervo, S., Camarero, T. G., Ongay, A. G., Sánchez-Moreno, L., Alonso‐Lecue, P., Naranjo-Gozalo, S., et al. (2024) · Heart Lung and Circulation · doi:10.1016/j.hlc.2023.12.019 · Cited by 2
The Risk of Pretransplant Blood Transfusion for Primary Graft Dysfunction After Lung Transplant
Kaihou, T., Toyoda, T., Cerier, E. J., Yagi, Y., Manerikar, A. J., Thomae, B. L., Kandula, V., Bharat, A., & Kurihara, C. (2024) · Annals of Thoracic Surgery Short Reports · doi:10.1016/j.atssr.2024.02.004 · Cited by 2
Yang, J., Xie, X., Li, J., Li, Y., Li, B., Wang, C., & Jiang, P. (2024) · Perfusion · doi:10.1177/02676591241242018 · Cited by 2
Schaenman, J. M. D., Weigt, S. S., Pan, M., Lee, J. J., Zhou, X., Elashoff, D. A., Shino, M. Y., Reynolds, J. M., BUDEV, M. M., Shah, P., et al. (2024) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2024.07.011 · Cited by 2
Self-citationDonor lung weight a novel predictor for primary graft dysfunction
Martinsson, A., Thorén, A., Ricksten, S., Oras, J., Abed, M., Vestlund, P., Magnusson, J. M., & Wallinder, A. (2025) · JHLT Open · doi:10.1016/j.jhlto.2025.100271 · Cited by 3
Immunologische Aspekte nach der Lungentransplantation
Hillebrand, C., & Benazzo, A. (2025) · Zentralblatt für Chirurgie - Zeitschrift für Allgemeine Viszeral- Thorax- und Gefäßchirurgie · doi:10.1055/a-2590-9933 · Cited by 2
Pulmonary Hypertension in Orphan Lung Diseases
Montani, D., Girerd, B., Seferian, A., Godinas, L., & Humbert, M. J. C. (2014) · Springer eBooks · doi:10.1007/978-1-4471-2401-6_33 · Cited by 2
“Finally, because of the poor prognosis of SAPH and the lack of effi cacy of specifi c PAH therapy, lung transplantation should be considered earlier in the course of the disease, despite the fact that the presence of PH prior to lung transplantation represents a risk factor of peri-transplant mortality [ 26 ] and prim…”
BackgroundPulmonary Hypertension in Idiopathic Pulmonary Fibrosis
Rivera‐Lebron, B. N. (2013) · Advances in Pulmonary Hypertension · doi:10.21693/1933-088x-12.3.127 · Cited by 2
Factors affecting complications development and mortality after single lung transplant
Sekulovski, M., Simonska, B., Peruhova, M., Krastev, B. M., Peshevska-Sekulovska, M., Spassov, L., & Velikova, T. V. (2021) · World Journal of Transplantation · doi:10.5500/wjt.v11.i8.320 · Cited by 2
Donor substance use and lung transplantation: A single center experience
Liu, C., Heid, C. A., Hauptmann, E., Ali, M. H., Pruszynski, J. E., Pillai, A., Banga, A., Wait, M. A., Huffman, L. C., Peltz, M., et al. (2022) · Transplantation Reports · doi:10.1016/j.tpr.2022.100124 · Cited by 2
Moreno, P., & Álvarez, A. (2023) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezad081 · Cited by 2
Nunley, D. R., Gualdoni, J., Ritzenthaler, J. D., Bauldoff, G. S., Howsare, M. M., Reynolds, K. G., van Berkel, V. H., & Roman, J. (2023) · Transplantation Proceedings · doi:10.1016/j.transproceed.2023.03.085 · Cited by 2
Ozone and Acute Respiratory Distress Syndrome: It’s in the Air We Breathe
Reilly, J. P. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201512-2517ed · Cited by 2
Transfusion and Primary Graft Dysfunction After Lung Transplantation: All About the Ratio?
Syrett, A., & Huang, A. (2020) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2020.07.012 · Cited by 2
Greif, B. (2023) · Slovenian Medical Journal · doi:10.6016/zdravvestn.3327 · Cited by 1
Imaging in Lung Transplantation
Kang, J., & Digumarthy, S. R. (2023) · Radiologic Clinics of North America · doi:10.1016/j.rcl.2023.04.006 · Cited by 1
Post‐Transplant Phase: Issues in the Early Postoperative Period
Mackintosh, J. A., & Hopkins, P. M.-A. (2023) · Wiley eBooks · doi:10.1002/9781119633884.ch89 · Cited by 1
Outcomes of single-lung retransplantation after double-lung transplantation
Yin, V., Rodman, J., Atay, S. M., Wightman, S. C., Rosenberg, G. M., Udelsman, B. V., Ganesh, S., Chung, P., Kim, A. W., & Harano, T. (2024) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2024.09.039 · Cited by 1
Perioperative Bleeding Risk in Lung Transplantation After Previous Cardiothoracic Surgery
Chow, B., Rosser, M. A., Klapper, J. A., Mamoun, N. F., Hartwig, M. G., Wu, K. A., Poisson, J. L., Young, K. A., Ghadimi, K., Welsby, I. J., et al. (2025) · Clinical Transplantation · doi:10.1111/ctr.70151 · Cited by 1
Management of pharmacotherapy in lung transplant candidates
Rudzik, K. N., & Lyster, H. S. (2025) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000001172 · Cited by 1
“Additionally, elevated pulmonary artery pressures at the time of lung transplantation increases risk of primary graft dysfunction [73,74].”
Ma, Y., Geng, Y., Wang, D., Wu, Z., Yang, X., Ma, L., Chang, R., Meng, B., & Zhu, Z. (2025) · Asian Journal of Surgery · doi:10.1016/j.asjsur.2025.03.002 · Cited by 1
Reduced left atrial compliance exacerbates primary graft dysfunction after lung transplantation
Schäfer, M., Selzman, C. H., DiChiacchio, L., Heiler, J. C., Ramakrishna, S., Tumarkin, E., Hill, B., Kagawa, H., Contreras, N., Raman, S. M., et al. (2025) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2025.04.020 · Cited by 1
Chuachao, P., Devaquet, J., Sage, E., Vallée, A., Guen, M. L., Fischler, M., & Fessler, J. (2025) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2025.04.033 · Cited by 1
Anesthesia for lung transplantation: A narrative review
Khanna, S., Das, J., Kumar, S., & Mehta, Y. B. (2025) · Journal of Anaesthesiology Clinical Pharmacology · doi:10.4103/joacp.joacp_259_24 · Cited by 1
“[25] Management includes protocolized perioperative care minimizing the risk factors as far as possible, lung protective strategy for mechanical ventilation, inhaled pulmonary vasodilators (nitric oxide [NO]), controlled reperfusion, and use of antioxidants like N ‑acetylcysteine and vitamin C.”
Kagawa, H., Contreras, N., Goodwin, M., Frye, L., Raman, S. M., Cahill, B. C., Hachem, R. R., Morrell, M. R., & Selzman, C. H. (2025) · Transplantation Reviews · doi:10.1016/j.trre.2025.100989 · Cited by 1
Villavicencio, M. A., Saddoughi, S. A., Spencer, P. J., Fox, M. P., Bermudez, C. A., Whitson, B. A., Choi, K., Kashem, A. M., Pennington, K. M., Yalamuri, S. M., et al. (2026) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2025.12.021 · Cited by 3
Oliveira, R. E. N. D. N., Passos, F. S., Salvador, I. C. M. C., Silva, I. D. A., de Lima, A. S., Pessoa, B. M., & Bello, I. (2026) · Current Transplantation Reports · doi:10.1007/s40472-025-00500-9 · Cited by 2
“Survival rates in lung transplantation are influenced by numerous factors beyond the surgical approach, including preoperative health status, donor quality, and postoperative care [42 – 45 ].”
Shemesh, A., Carter, S., Hays, S. R., Singer, J. P., Greenland, J. R., & Calabrese, D. R. (2026) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1093/ajrcmb/aanag017 · Cited by 1
Anderson, M. R., Gallop, R., Localio, A. R., Oyster, M. L., Kalman, L., Griffiths, S., Hartwig, M. G., Snyder, L. D., Shashaty, M., Ahya, V. N., et al. (2026) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2026.08.016 · Cited by 1
Self-citationMohammed, B. K., Muskaan, A., Syed, Y. P. Q., Prasad, A. J., Sheikh, M., Devarakonda, T., & Kumar, A. (2026) · Journal of Robotic Surgery · doi:10.1007/s11701-026-03965-7 · Cited by 1
Ramesh, B. C. (2014) · Interactive Cardiovascular and Thoracic Surgery · doi:10.1093/icvts/ivu060 · Cited by 1
Lung Transplantation and the Blood–Gas Barrier
Schnapper, A., & Ochs, M. (2015) · Springer eBooks · doi:10.1007/978-3-319-18392-3_9 · Cited by 1
Cardiovascular and Pulmonary Research: The Year (2021) in Review
Ricard, P. E. H., McHugh, H. F., & Ramsey, S. (2022) · Cardiopulmonary Physical Therapy Journal · doi:10.1097/cpt.0000000000000209 · Cited by 1
Postoperative Critical Care of Lung Transplant Patients
Rio, J. M. D., Daneshmand, M. A., & Hartwig, M. G. (2016) · Springer eBooks · doi:10.1007/978-1-4939-6377-5_10 · Cited by 1
Ethical Issues in Organ Transplantation
Ramos, H. C., & McCauley, J. (2017) · Springer eBooks · doi:10.1007/978-3-319-14779-6_26-1 · Cited by 1
Perioperative Care for Lung Transplant Recipients: A Multidisciplinary Approach
Brann, S. H., Geier, S. S., Timofeeva, O. A., Shigemura, N., CORDOVA, F. C., & Toyoda, Y. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.85277 · Cited by 2
Талызин, А. М., Zhuravel, S. V., Khubutiya, M. S., Tarabrin, E. A., & Kuznetsova, N. K. (2021) · Transplantologiya The Russian Journal of Transplantation · doi:10.23873/2074-0506-2021-13-3-248-259 · Cited by 1
Yamamoto, H., Sugimoto, S., Imanishi, K., Hashimoto, K., Miyoshi, K., Otani, S., Yamane, M., & Toyooka, S. (2021) · Journal of Thoracic Disease · doi:10.21037/jtd-21-1119 · Cited by 1
“Consequently, the use of anticoagulation for cardiopulmonary support could increase the risk of massive hemorrhage and the need for massive fluid infusion and blood/blood product transfusion during LT, which increases the risk of development of PGD after LT (9).”
BackgroundBerry, G. J. (2016) · Springer eBooks · doi:10.1007/978-3-319-29683-8_5 · Cited by 1
Regression of Tricuspid Valve Regurgitation After Lung Transplant: A Single-Center Experience
Jacob, S., Ahmed, M. M. E., Haddad, O. K., Orlando, D., Landolfo, C. K., Thomas, M., Makey, I. A., Sareyyüpoğlu, B., Landolfo, K. P., & Pham, S. M. (2022) · Transplantation Proceedings · doi:10.1016/j.transproceed.2022.08.004 · Cited by 1
Pulmonary hypertension in orphan lung diseases
Montani, D., Kularatne, M., Jutant, E., & Humbert, M. J. C. (2023) · European Respiratory Society eBooks · doi:10.1183/2312508x.10018522 · Cited by 2
Luo, X., Yu, S., Liu, B., Zheng, Q., Zhou, X., An, K., Zhong, J., Wu, L., Dai, H., Qi, Z., et al. (2024) · Transplantation · doi:10.1097/tp.0000000000004979 · Cited by 1
Anesthetic considerations for perioperative ECMO in lung transplantation
Fessler, J., Vajter, J., & Martin, A. K. (2024) · Best practice & research. Clinical anaesthesiology · doi:10.1016/j.bpa.2024.03.002 · Cited by 1
Miano, T. A., Zuppa, A. F., Feng, R., Griffiths, S., Kalman, L., Oyster, M. L., Cantu, E., Yang, W. P., Diamond, J. M., Christie, J. D., et al. (2024) · JHLT Open · doi:10.1016/j.jhlto.2024.100134 · Cited by 2
“13 We merged LTOG data with electronic health record data (medications, tacrolimus concentrations, and other laboratory values) for the current analysis.”
Self-citationSemmelmann, A., Moneke, I., Autenrieth, J., Baar, W., & Loop, T. (2024) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2024.08.002 · Cited by 1
Morgan, S., Åneman, A., Olsen, N., & Nair, P. (2025) · Acta Anaesthesiologica Scandinavica · doi:10.1111/aas.70030 · Cited by 1
New Techniques for the Optimization of Donor Lungs/Hearts
Braithwaite, S. A., Blankman, P., & van der Kaaij, N. P. (2025) · Anesthesiology Clinics · doi:10.1016/j.anclin.2025.02.005 · Cited by 1
Rising to the Challenge of Unmet Need: Expanding the Lung Donor Pool
Ali, A., Keshavjee, S. H., & Cypel, M. (2018) · Current Pulmonology Reports · doi:10.1007/s13665-018-0205-4 · Cited by 1
Pulmonary Hypertension and Thoracic Surgery: Impact and Treatment Options
Francis, L. R., Whitener, S. K., McKinnon, J. S., & Whitener, G. B. (2019) · Current anesthesiology reports · doi:10.1007/s40140-019-00360-x · Cited by 1
Kumar, A. (2020) · Springer eBooks · doi:10.1007/978-981-15-0746-5_17 · Cited by 1
Jiang, Y. (2015) · D-Scholarship@Pitt (University of Pittsburgh) · Cited by 2
Why Does the Transplanted Lung Sometimes Fail to Work?
Glanville, A. R. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201212-2335ed · Cited by 1
Donor-recipient lung size mismatch: A provocative data set
Mallory, G. B. (2013) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2013.10.011 · Cited by 1
Corris, P. A., Small, T., Ryan, V. A., Lordan, J., Fisher, A. J., Meachery, G. J., Johnson, G. E., & Ward, C. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a5324 · Cited by 1
How Would You Grade Our Progress in Primary Graft Dysfunction after Lung Transplantation?
Neyrink, A., & Verleden, G. M. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201709-1952ed · Cited by 1
Lamb, C. A., & Kirby, J. A. (2018) · Thorax · doi:10.1136/thoraxjnl-2017-210274 · Cited by 1
“Increased length of ischaemic time has also been associated with the condition.(6) This observation has led to the development of ex vivo lung perfusion (EVLP).”
BackgroundAnesthesia for Heart and Lung Transplantation
Farmer, B. E., & Zhukov, I. O. (2018) · Springer eBooks · doi:10.1007/978-3-319-74766-8_4 · Cited by 1
Bradley, E. A., Boucly, A., & Benza, R. L. (2020) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2020.05.014 · Cited by 1
“This is largely driven by the concern that patients with PAH are high-risk and have increased potential for post-transplant graft dysfunction and increased resource utilization.(3) However, some studies have demonstrated that up-front risk stratification of patients with PAH according to estimates of 1-year mortality…”
BackgroundCommentary: Lung transplant: No support is best
Chang, S. H., & Henn, M. C. (2021) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2021.11.050 · Cited by 1
Primary graft dysfunction following lung transplant: Unknowns best ushered by knowns
Magoon, R., & Jose, J. (2022) · Acta Anaesthesiologica Scandinavica · doi:10.1111/aas.14055 · Cited by 1
Genomic and Proteomic Approaches to Lung Transplantation
Noel, J., Carnemolla, R., & Chatterjee, S. (2015) · Wiley eBooks · doi:10.1002/9781118930458.ch23
N-Acetylcysteine Protection in COPD
Wu, W., Awab, A., & Metcalf, J. P. (2014) · CHEST Journal · doi:10.1378/chest.13-2029
Considerations for Lung Transplantation in Patients With Idiopathic Pulmonary Fibrosis
Perlman, D., Loor, G., Kim, H. J., & Tomic, R. (2015) · Clinical Pulmonary Medicine · doi:10.1097/cpm.0000000000000083
Long Term Impact of Primary Graft Dysfunction after Lung
Hachem, R. R. (2015)
Hypoxic Pulmonary Hypertension
Goss, K. N., & Lahm, T. (2015) · Respiratory medicine · doi:10.1007/978-1-4939-2636-7_4
Bermudez, C. A., & Mahesh, B. (2015) · Springer eBooks · doi:10.1007/978-3-319-23594-3_19
Extrakorporale Unterstützungsverfahren bei Lungentransplantation
Schmack, B., Weymann, A., Zych, B., Sabashnikov, A., Großekettler, L., Ruhparwar, A., Karck, M., Simon, A. R., & Popov, A. (2016) · Zeitschrift für Herz- Thorax- und Gefäßchirurgie · doi:10.1007/s00398-016-0090-5
“ZahlreicheArbeiten haben eine Assoziation zwischen der Anwendung einer EKZ und einer erhöhten Rate an primärem Transplantatversagen („primary graft failure“, PGF) und damit mit einer erhöhten Sterblichkeit dargestellt [1, 8, 10, 15, 20].”
BackgroundSommer, W., & Warnecke, G. (2015) · CRC Press eBooks · doi:10.1201/b19234-9
Cheng, A. M., Mulligan, M. S., & Togashi, K. (2015) · Advances in medical technologies and clinical practice book series · doi:10.4018/978-1-4666-8603-8.ch027
A Review of Lung Transplantation for Patients With α-1 Antitrypsin Deficiency
Banga, A., Rokadia, H. K., & Stoller, J. K. (2015) · Clinical Pulmonary Medicine · doi:10.1097/cpm.0000000000000119
Skeletal Muscle Dysfunction in Lung Transplant Patients
Rozenberg, D. (2017) · TSpace (University of Toronto)
Meachery, G. J., & Corris, P. A. (2018) · Springer eBooks · doi:10.1007/978-3-319-91184-7_2
New Horizons in Lung Transplantation
Sánchez, P. G., Walters, D. M., & Mulligan, M. S. (2018) · Springer eBooks · doi:10.1007/978-3-319-91184-7_20
Physiologic and Epigenetic Changes with Pulmonary Vascular Injury After Lung Transplantation
Huang, S. K., Carbone, R. G., & Bottino, G. (2018) · Springer eBooks · doi:10.1007/978-3-319-91184-7_10
Lung Transplantation for Pulmonary Arterial Hypertension
Whitford, H. M. (2018) · Springer eBooks · doi:10.1007/978-3-319-90933-2_14
Primary graft dysfunction and beyond after lung transplantation in the current era
Shigemura, N. (2018) · Transplant International · doi:10.1111/tri.13385
“4% (6 + 40/237), which appears to be close to the currently reported results with severe PGD from other major lung transplant centers [5]; however, it”
ResultKlapper, J. A. (2019) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2019.03.037
Commentary: Portable, normothermic ex vivo lung perfusion—High hopes, not yet fully realized
Javidfar, J. (2019) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2019.03.044
Anesthesia for Lung Transplantation
Roberts, J. D. (2019) · Oxford University Press eBooks · doi:10.1093/med/9780190884512.003.0032
Early postoperative complications after lung transplantation
Pashkov, I. V., Попцов, В. Н., Oleshkevich, D. O., & Gautier, S. V. (2019) · Russian Journal of Transplantology and Artificial Organs · doi:10.15825/1995-1191-2019-2-125-137
Manejo de la hipertensión arterial pulmonar: estratificación pronóstica y opciones terapéuticas
Loaiza, C. A. Q. (2019) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Sacreas, A., & Verleden, S. E. (2020) · Annals of Translational Medicine · doi:10.21037/atm.2020.01.110
Metadata
- Authors
- Diamond, J. M., Lee, J. C., Kawut, S. M., Shah, R. J., Localio, A. R., Bellamy, S. L., Lederer, D. J., Cantu, E., Kohl, B. A., Lama, V. N., Bhorade, S. M., Crespo, M., Demissie, E., Sonett, J., Wille, K., Orens, J., Shah, A. S., Weinacker, A., Arcasoy, S., Shah, P. D., Wilkes, D. S., Ware, L. B., Palmer, S. M., & Christie, J. D.
- Affiliations
- University of Pennsylvania (US)
- Columbia University (US)
- University of Michigan (US)
- University of Chicago (US)
- University of Pittsburgh (US)
- University of Alabama at Birmingham (US)
- Johns Hopkins University (US)
- Stanford University (US)
- Indiana University Indianapolis (US)
- Vanderbilt University (US)
- Duke University (US)
- Corresponding author
- Diamond, Joshua M.
- ORCID
- Diamond, Joshua M.
- Kawut, Steven M.
- Shah, Rupal J.
- Localio, A. Russell
- Bellamy, Scarlett L.
- Lederer, David J.
- Cantu, Edward
- Kohl, Benjamin A.
- Lama, Vibha N.
- Bhorade, Sangeeta M.
- Crespo, Maria
- Wille, Keith
- Shah, Ashish S.
- Weinacker, Ann
- Arcasoy, Selim
- Shah, Pali D.
- Wilkes, David S.
- Ware, Lorraine B.
- Palmer, Scott M.
- Christie, Jason D.
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-03-01
- Volume
- 187
- Issue
- 5
- Pages
- 527-534
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- PMC
- PMC3733407
- OpenAlex
- W2073264366
- Cited by
- 687
- References
- 34
- Citations by year
- 2026: 35 · 2025: 55 · 2024: 73 · 2023: 65 · 2022: 54 · 2021: 58 · 2020: 46 · 2019: 44 · 2018: 48 · 2017: 53 · 2016: 46 · 2015: 42 · 2014: 45 · 2013: 15
- FWCI
- 48.59
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- American Journal of Respiratory and Critical Care Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Institutes of Health
- National Heart, Lung, and Blood Institute (R01HL096845, K24HL103836, R01HL114626, R01HL081619, R01HL087115, K23HL116656, K24HL115354)
- Topics
- Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
- Health Sciences › Medicine › Surgery › Organ Transplantation Techniques and Outcomes
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Organ Donation and Transplantation
- Keywords
- primary graft dysfunction, lung transplantation, risk factors, fraction of inspired oxygen, single lung transplantation, cardiopulmonary bypass, obesity, sarcoidosis, pulmonary arterial hypertension, mean pulmonary artery pressure, donor-recipient mismatch, donor sex, donor body mass index
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Female, Humans, Male, Middle Aged, Prospective Studies, Risk Factors, United States, Multivariate Analysis, Logistic Models, Lung Transplantation, Primary Graft Dysfunction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.